Sophisticated Endoscopic Medical Devices

[INQ. NO. 2607E05] MediInTech Co., Ltd., established in 2020, is a specialized medical-device company committed to developing intuitive and intelligent endoscopic medical devices.
By challenging the flexible endoscope market, which is dominated by Japanese companies with over 90% market share, MediInTech has gained attention for its domestically developed endoscope, MEDIUFES.
MEDIUFES is an innovative motorized gastrointestinal endoscopic system that addresses the shortcomings of traditional mechanical endoscopes.
Powered by artificial intelligence (AI) software, it enhances convenience for medical professionals and ensures safety for patients. Through this product, MediInTech aims to lead the localization of medical devices in Korea while also strengthening its competitiveness in global markets.

MEDIUFES boasts advanced technology that significantly improves the convenience and efficiency of medical professionals. The company particularly aims to target markets facing a shortage of skilled healthcare professionals by highlighting the value of motorized and AI-driven solutions.

MEDIUFES is a sophisticated medical endoscopic system comprising the MEDIUFES Video System (ME-400), Video Gastroscopy (MGS-400, MGS-410), Video Colonoscopy (MCS-400, MCS-410), Video Broncoscopy (MBS-440, MBS-460), and endoscopic video analysis software (MD-SA-300, MD-CA-300). The MEDIUFES Video System (ME-400) features an intuitive control interface, motorized suction capabilities, and a USB 3.0 port for image and video data transfer. The Video Gastroscopy (MGS-400, MGS-410) delivers high-resolution FHD images and offers intuitive control through its motorized esophagogastroduodenoscope.
The Video Colonoscopy (MCS-400, MCS-410) offers effortless control through a wheel or joystick-based interface. The Video Broncoscopy (MBS-440, MBS-460) is designed for the diagnosis and treatment of the bronchi and lungs. The endoscopic video analysis software (MD-SA-300, MD-CA-300) features real-time detection of abnormalities, combining high-quality data from specialists at Seoul National University Hospital with MediInTech’s proprietary technology.

MediInTech has identified Vietnam, Thailand, Indonesia, and the Philippines as its primary target markets. These countries were selected due to their regulatory frameworks that allow entry without FDA or CE certifications, as well as their promising medical device and endoscopy market-growth potential. Vietnam has already secured regulatory approval and finalized distributor appointments, while regulatory applications are underway in the remaining countries.
MediInTech has also set its sights on the United States as a secondary target, aiming to enter the American market after obtaining FDA approval.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods